Home World News FOLFIRINOX Improves PFS Compared with Gemcitabine in Patients with Locally Advanced Pancreatic... World News FOLFIRINOX Improves PFS Compared with Gemcitabine in Patients with Locally Advanced Pancreatic Carcinoma By Ogkologos - May 26, 2025 635 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PRODIGE 29-UCGI 26 (NEOPAN) study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Responding to Coronavirus, Cancer Researchers Reimagine Clinical Trials June 29, 2020 Building a Support Community During Cancer: “Your Stories” Podcast December 14, 2021 A Meaningful Benefit of the Quadruplet-Based Isatuximab Plus VRd Regimen in... July 11, 2024 Neoadjuvant Nivolumab Plus Ipilimumab Leads to a Pathological Response in a... June 12, 2024 Load more HOT NEWS 细针穿刺活检：如何准备和会发生什么 Aiming to Prevent New Cancer Cases, ESMO Calls for Increased Minimum... ESMO Breast Cancer Virtual Congress 2021, 5-8 May Trial Should Change Care for AIDS-Related Kaposi Sarcoma in Sub-Saharan Africa
